Xiangyu Medical News

Xiangyu Healthcare (688626): Performance continues to be under pressure, waiting for the industry to pick up

central china securitiesNov 4 00:00

Xiangyu Healthcare (688626): 24H1 performance is under pressure and continues to increase R&D investment

國信證券Sep 13 14:51

Xiangyu Medical (688626): R&D and sales investment increased 2024H1 net profit under short-term pressure

Sep 2 00:00

Xiangyu Healthcare (688626): Industry-university-research innovation advantages highlight driving both revenue and profit growth

May 7 13:42

Guoxin Securities released a research report on April 25 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) rapid growth in performance in 2023, strong recovery in demand for rehabilitation d

Zhitong FinanceApr 25 10:49

Xiangyu Medical (688626): Net profit due to mother increased by 81% in 2023 and continued to increase R&D investment

Apr 25 10:11

Guohai Securities released a research report on April 23 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) achieving relatively rapid growth in performance; 2) focusing on shareholder return

Zhitong FinanceApr 24 16:22

Xiangyu Medical (688626): R&D builds competitive advantage, and performance achieves rapid growth

Apr 23 00:00

Open Source Securities released a research report on April 19 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) rapid growth in 2023 performance, outstanding market advantages for a full ran

Zhitong FinanceApr 19 15:57

Xiangyu Healthcare (688626) 2023 Annual Report and 2024 Quarterly Report Review: Strong business recovery in 2023, equity incentives show confidence

Apr 18 18:11

Xiangyu Healthcare (688626): Steady growth in performance, optimistic about high-end layout

Apr 18 00:00

Xiangyu Medical (688626): Rehabilitation devices welcome a golden period of development, leading domestic producers set sail

Mar 16 00:00

Commentary on the 2023 Three-Quarter Report of Xiangyu Healthcare (688626): Strong performance recovery momentum, long-term optimism about rehabilitation demand

Nov 1, 2023 00:00

Xiangyu Medical (688626): Product upgrade+rapid increase in scale effect is sustainable

ZheshangOct 26, 2023 07:32

Xiangyu Healthcare (688626): Achieving rapid growth in revenue, equity incentives highlight confidence in growth

信達證券Sep 4, 2023 00:00

Xiangyu Medical (688626): Performance growth accelerates and the leading position in rehabilitation equipment is stable

興業證券Aug 22, 2023 13:07

XIANGYU MEDICAL(688626):ACCELERATED PERFORMANCE GROWTH LEADING POSITION OF REHABILITATION DEVICES CONSOLIDATED

兴业证券Aug 22, 2023 00:00

Xiangyu Medical (688626) 2023 Interim Report Review: Strong Performance Recovery Momentum, Equity Incentives Show Confidence

中信證券Aug 18, 2023 00:00

Xiangyu Healthcare (688626) Interim Report: Demand for rehabilitation picked up after the pandemic

中原證券Aug 12, 2023 00:00

Xiangyu Medical (688626) Company Information Update Report: Rapid Growth in Performance and Strong Comprehensive Strength Entering the Fast Track of Development

開源證券Aug 8, 2023 13:42